As compared with the control group , the treatment-interruption group had a mean CD4 cell count that was 85 cells per cubic millimeter lower from months 0 through 4 ( P < 0.001 ) , 47 cells per cubic millimeter lower from months 5 through 8 ( P < 0.001 ) , and 31 cells per cubic millimeter lower after eight months ( P = 0.11 ) .
